Mark Morais

Mark Morais

Mark Morais has served as Fortrea’s Chief Operations Officer and President, Clinical Development since May 2023. In this role, he is responsible for the strategy and delivery of Fortrea’s clinical operations inclusive of its full-service CRO, functional service provider offerings and therapeutic expansion.

Mark brings more than two decades of experience in the CRO industry, including a successful track record in operational optimization and commercial development. Working closely with clients, he has helped shape the design of strategic alliances and preferred-provider relationships. Mark held a number of leadership positions at Labcorp Drug Development, prior to Fortrea’s spinoff from Labcorp. He served as President of Clinical Operations and Commercial Services from 2020 to 2023. Previous roles included Senior Vice President of Strategic Deal Development and Alliance Management, and Vice President of Strategic Deal Development and Pricing. Prior to joining Labcorp Drug Development, Mark served at Quintiles/IQVIA from 2001 to 2016, where he held global leadership positions in both Commercial Development and Clinical Operations. 

Mark received his bachelor's degree in Economics from North Carolina State University and has served multiple terms in on the Poole College of Management advisory board.